Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Y Cho

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cell Reports|October 17, 2019
Magnitude of Therapeutic STING Activation Determines CD8<sup>+</sup> T Cell-Mediated Anti-tumor ImmunityKelsey E Sivick, Anthony L Desbien, Laura Hix Glickman, et al.
Cell Reports|December 13, 2018
Magnitude of Therapeutic STING Activation Determines CD8<sup>+</sup> T Cell-Mediated Anti-tumor ImmunityKelsey E Sivick, Anthony L Desbien, Laura Hix Glickman, et al.
Nature|July 29, 2011
Oxysterols direct immune cell migration via EBI2Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Nature Chemical Biology|October 12, 2023
Activation of human STING by a molecular glue-like compoundJie Li, Stephen M Canham, Hua Wu, et al.
Journal of Medicinal Chemistry|May 19, 2026
Targeting Multiple KRAS Mutations with High-Affinity Macrocyclic Inhibitors: From Discovery to Preclinical ValidationDean P Phillips, Phil B Alper, Charles Y Cho, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cell Reports|October 17, 2019
Magnitude of Therapeutic STING Activation Determines CD8<sup>+</sup> T Cell-Mediated Anti-tumor ImmunityKelsey E Sivick, Anthony L Desbien, Laura Hix Glickman, et al.
Cell Reports|December 13, 2018
Magnitude of Therapeutic STING Activation Determines CD8<sup>+</sup> T Cell-Mediated Anti-tumor ImmunityKelsey E Sivick, Anthony L Desbien, Laura Hix Glickman, et al.
Nature|July 29, 2011
Oxysterols direct immune cell migration via EBI2Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Nature Chemical Biology|October 12, 2023
Activation of human STING by a molecular glue-like compoundJie Li, Stephen M Canham, Hua Wu, et al.
Journal of Medicinal Chemistry|May 19, 2026
Targeting Multiple KRAS Mutations with High-Affinity Macrocyclic Inhibitors: From Discovery to Preclinical ValidationDean P Phillips, Phil B Alper, Charles Y Cho, et al.
Pageof 3